ClinicalTrials.Veeva

Menu

Evaluation of Microinvasive Glaucoma Surgery: MINIject® Versus Hydrus® Microstent in Combination With Cataract Surgery (MINHY)

M

Medical University of Graz

Status

Enrolling

Conditions

Cataract
Glaucoma

Treatments

Device: MINIject with Cataract Surgery
Device: Hydrus Microstent with Cataract Surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT06844292
1242/2024

Details and patient eligibility

About

The study aims to investigate postoperative outcomes after two different MIGS implants (MINIject or Hydrus) in combination with cataract surgery for patients with glaucoma.

Full description

The study aims to investigate postoperative outcomes in terms of intraocular pressure as well as safety measures after two different MIGS implants (MINIject® or Hydrus®) in conjunction with cataract surgery (CS) for patients with chronic glaucoma. The patients will be followed up for 5 years after the date of their implantation. Standard ophthalmologic assessments including measurement of intraocular pressure, fundus examination and ocular imaging with OCT (Optical Coherence Tomography). Assessment of life quality as well as adverse events will be performed.

Enrollment

152 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with glaucoma in which surgery is indicated to reach target intraocular pressure as well as lens opacities where CS is indicated
  • Clinically eligible for both surgeries
  • Subjects not anticipated to require any further surgery in the next 12 months
  • Patients' age > 18 years

Exclusion criteria

  • Patients who do not want to make follow-ups at the department
  • Angle closure, uveitic, neovascular, congenital glaucoma, iridocorneal endothelial syndrome, Axenfeld-Rieger syndrome
  • Prior filtering glaucoma surgery, suprachoroidal stent, retinal surgery, corneal graft surgery or cyclophotocoagulation
  • Allergy to any drugs or substances required for the protocol
  • Pregnant women

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

152 participants in 2 patient groups

MINIject
Active Comparator group
Description:
MINIject with Cataract Surgery
Treatment:
Device: MINIject with Cataract Surgery
Hydrus Microstent
Active Comparator group
Description:
Hydrus Microstent with Cataract Surgery
Treatment:
Device: Hydrus Microstent with Cataract Surgery

Trial contacts and locations

1

Loading...

Central trial contact

Lena M Haiden, MD; Ewald Lindner, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems